SPONSOR
Saint Vincent's Hospital, Korea
Total Trials
2
Recruiting
2
Phases
Phase 4
Saint Vincent's Hospital, Korea is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Gallbladder Cancer, Coronary Artery Disease, Dyslipidemias, Primary Prevention.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Saint Vincent's Hospital, Korea
How many clinical trials has Saint Vincent's Hospital, Korea sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Saint Vincent's Hospital, Korea, of which 2 are actively recruiting participants. These trials cover conditions including Gallbladder Cancer, Coronary Artery Disease, Dyslipidemias. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Saint Vincent's Hospital, Korea research focus on?
Saint Vincent's Hospital, Korea clinical trials span Gallbladder Cancer, Coronary Artery Disease, Dyslipidemias, Primary Prevention. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Saint Vincent's Hospital, Korea clinical trial?
To participate in a Saint Vincent's Hospital, Korea trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Saint Vincent's Hospital, Korea trials with current recruitment status updated daily.
Clinical Trials by Saint Vincent's Hospital, Korea
NCT02920554
Recruiting
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer
Gallbladder Cancer
NCT06186037 Phase 4
Recruiting
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Coronary Artery Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology